Lepu Pharmaceutical (Beijing) Co., Ltd. (hereinafter referred to as Lepu Pharmaceutical (Beijing) Company) is a controlling subsidiary of the pharmaceutical segment of Lepu Medical Technology (Beijing) Co., Ltd. (hereinafter referred to as Lepu Medical). The company was restructured and established on the basis of the acquisition of Beijing Yongzheng Pharmaceutical Co., Ltd. (hereinafter referred to as Yongzheng Pharmaceutical). Its predecessor, Yongzheng Pharmaceutical, was founded in 1998 and is a modern pharmaceutical enterprise integrating drug research and development, production, and sales. The company is located in Baishan Town, Changping District, where the air is fresh and transportation is convenient. It is 3.5 kilometers west of the Badaling Expressway and Shahe University Town, and 2.5 kilometers east of Xiaotangshan, the home of hot springs. It covers an area of 98 mu, with a greening area of 40%, making it a garden-style enterprise with a beautiful environment. As one of the first pharmaceutical enterprises in Beijing to pass the new version of GMP certification, the company has 35 varieties in three dosage forms: tablets, granules, and capsules. The antipyretic-analgesic product "Surong-Nimesulide Dispersible Tablets", as the company's flagship product, firmly occupies the * camp. "Amlodipine Besylate Tablets" and "Isosorbide Mononitrate Tablets" are products highly compatible with Lepu Medical's cardiovascular medical devices, and are also mature and classic cardiovascular drugs. With the gradual integration of the market, sales are expected to soar. Lepu Medical is the parent company of Lepu Pharmaceutical (Beijing) Company. It is a large-scale manufacturing enterprise of cardiovascular interventional medical products controlled by a central state-owned enterprise, jointly funded by the 725th Research Institute of China Shipbuilding Industry Corporation and the American WP Company. It is one of the first 28 enterprises listed on the ChiNext Board of the Shenzhen Stock Exchange in 2009, and in November 2014 it was selected as one of the 50 sample stocks of the CCTV Finance 50 Index for 2014. As a * enterprise in the cardiovascular medical device industry, Lepu Medical has further broadened its related fields and product lines in cardiovascular treatment through vigorous mergers and acquisitions in the pharmaceutical field, enhancing the overall brand influence of Lepu Medical in the cardiovascular medical field. The asset acquisition and restructuring with Yongzheng Pharmaceutical can be described as a model of integration with complementary advantages and resource sharing between the two parties. Relying on Lepu Medical's diversified industrial development platform and years of industry accumulation, the newly established Lepu Pharmaceutical (Beijing) Company will be like a tiger with wings, reaching new levels and scaling new heights in the field of pharmaceutical preparation and research and development. Lepu Pharmaceutical (Beijing) Company will continue to follow the business philosophy of "making quality medicines and building a quality enterprise". Under the new strategic pattern, it has clearly defined new positioning and work priorities: "ensure supply, ensure quality"; "ensure safety, control costs"; "respond to regulations, standardize and upgrade". It will further strengthen system construction, process construction, and team building, effectively integrate into Lepu Medical's advanced management concepts and mechanisms, and make due contributions to the implementation of Lepu Medical's strategic goals. Employment principle—"person-enterprise match, person-post match"; talent is the company's * resource! Team style—a team with a high sense of responsibility, mission, integrity, and vitality!
What does Lepu Pharmaceutical (Beijing) Co., Ltd. require? Who is Lepu Pharmaceutical (Beijing) Co., Ltd. hiring? recruitment: 在校学生类占比最多占36.4%,其次是技工类占36.4%. What education can get in at ? 大专占比最多占54.5%,其次是不限占36.4%. Work experience required at ? 不限占比最多占54.5%,其次是1-3年占27.3%. Where are the job locations at ? 北京占比最多占100%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows